● Recruiting

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Condition: Major Depressive Disorder · Sponsor: Neurocrine Biosciences

PhasePhase 3

Planned participants550

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.

This description comes directly from the study's public registry record.

Talk to the study team

Neurocrine Medical Information Call Center · 1-877-641-3461 · medinfo@neurocrine.com

Always discuss trial participation with your own doctor first.

Locations (60)

Neurocrine Clinical Site	Oceanside, California, United States	Recruiting
Neurocrine Clinical Site	Orange, California, United States	Recruiting
Neurocrine Clinical Site	San Jose, California, United States	Recruiting
Neurocrine Clinical Site	New Haven, Connecticut, United States	Recruiting
Neurocrine Clinical Site	Miami Gardens, Florida, United States	Recruiting
Neurocrine Clinical Site	Orlando, Florida, United States	Recruiting
Neurocrine Clinical Site	Palm Bay, Florida, United States	Recruiting
Neurocrine Clinical Site	Tampa, Florida, United States	Recruiting
Neurocrine Clinical Site	Iowa City, Iowa, United States	Recruiting
Neurocrine Clinical Site	Marrero, Louisiana, United States	Recruiting
Neurocrine Clinical Site	O'Fallon, Missouri, United States	Recruiting
Neurocrine Clinical Site	Albuquerque, New Mexico, United States	Recruiting

+ 48 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07196501